An NBC News article, “French authorities call for ban of Allergan textured breast implants” provides us with recent data on this issue. The number of BIA-ALCL diagnoses has gone from one per million to one per 2,832. The total number of cases now is 457 in the U.S. and approximately 700 worldwide. The number of deaths has risen from 9 to 16. The … [Read more...]
Breast Implants FDA March 2019 Meeting: Lymphoma Cancer Was A Main Topic
There was an FDA CDRH General and Plastic Surgery Devices Advisory Committee Meeting held on March 25-26, 2019. The first day was focused in large part on Breast Implant Associated Anaplastic Large-Cell Lymphoma (BIA-ALCL). This lymphoma cancer associated with breast implants is a rare type of blood cancer that is classified as a non-Hodgkin … [Read more...]
Breast Implants Lymphoma Cancer Cases Update February 2019 – US & Canada
In February 2019 the FDA announced that it has received a total of 660 medical device reports (MDRs) regarding breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), cases in the United States since 2010. This new total indicates an increase of about 246 new reports of breast implants lymphoma cancer cases in the past year. According … [Read more...]
Allergan Textured Breast Implants Recalled In Europe Due To BIA-ALCL
In December 2018 France’s National Agency for the Safety of Medicines and Health Products (ANSM) announced that Allergan textured breast implants can no longer be marketed in France and elsewhere in Europe. As regards what the FDA is doing on this developing medical device safety issue, we turn to this NBC News piece, “Allergan’s textured breast … [Read more...]
Several 2018 Breast Implant Lymphoma Cancer Lawsuits Already Filed
Background Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a type of non-Hodgkin's lymphoma, which is a cancer of the cells of the immune system. This rare T-cell lymphoma can develop as a result of breast implants, though the mechanism of injury is not fully understood at this time. However, based on current data from the … [Read more...]
UNCW Researchers Identify GenX in Rainwater and Sediment from the Cape Fear River
Current Situation The most recent results released by the Cape Fear Public Utility Authority (CFPUA) show that GenX is still present in the drinking water at 24 parts per trillion (ppt), which is well below the state's health goal of 140 ppt. While levels of GenX in the drinking water are declining, the concentrations already present in the … [Read more...]
FDA Provides Updated Number of Breast Implants Lymphoma Cancers
About BIA-ALCL The U.S. Food and Drug Administration (FDA) has been aware of the possible connection between breast implants and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) since 2011. This condition is a rare type of non-Hodgkin’s lymphoma, which is a cancer of the immune system, rather than a cancer of the breast … [Read more...]
Is the NC Senate’s GenX Bill Sufficient to Address GenX Contamination?
Today, February 13, 2018, the NC House of Representatives will potentially vote on House Bill 189, which concerns how to address the GenX contamination issue. This bill is referred to as the "Water Safety Act" and has undergone several revisions during its time in the Senate. However, some believe that the amendments are still not enough to get … [Read more...]
Judge Consolidates Five Existing GenX Contamination Lawsuits
In October of last year, five separate Complaints were filed against chemical companies DuPont and Chemours in response to the GenX contamination of the Cape Fear River. Here is a list of the Complaints that have been filed against DuPont and Chemours thus far: Cape Fear Public Utility Authority (CFPUA) Brunswick County Brent Nix … [Read more...]
New Data Released on Risk of Lymphoma Due to Breast Implants
Recent Study on BIA-ALCL RisksSince my last article on this topic, "What is the Risk of Death Due to Breast Implant-Associated Lymphoma?," additional information on the risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has been released. The most recent study, titled "Breast Implants and the Risk of Anaplastic Large-Cell … [Read more...]